Reports of Biochemistry and Molecular Biology · 2020 · 21 citations · 28 references
MedicineInternal MedicineClinical BiochemistryClinical NutritionDiabetologyCardiac BiomarkersCardiovascular DiseaseDiabetes MellitusC-reactive Protein TestingCreatinine-based BiomarkersDiabetes Mellitus AssociationsDiabetes-associated Cardiac RiskHemoglobin A1c TestingHypertension In Diabetes MellitusPlasma AlbuminPlasma Cholesterol Levels
BACKGROUND: The objective of this study was to determine the levels of serum ischemia-modified albumin (IMA), fibrinogen (FIB) and high sensitivity C-reactive protein (hs-CRP) in type 2 diabetes mellitus (T2DM) patients with hypertension (HT) (DMT2HTN) and without HT (DMT2). Also, their association with certain biochemical and physical factors were studied to identify possible risk factors that lead to cardiovascular complications. METHODS: Fasting blood samples were collected from 35 DMT2 or DMT2HTN patients each to analyze differences in serum and plasma levels of IMA, hs-CRP, FIB, total cholesterol (TC), high and low density lipoproteins (HDL and LDL), triglyceride (TG), hemoglobin A1c (HbA1C), glycated hemoglobin and creatinine. RESULTS: In DMT2 and DMT2HTN patients, IMA, hs-CRP, FIB, TC, TG, HDL, LDL, glycated hemoglobin and creatinine levels, including body mass index (BMI) and waist-to-hip ratio (WHR), were significantly higher relative to healthy controls. In addition, the levels of IMA, hs-CRP and FIB levels showed a strong link to BMI, WHR, TC, TG, LDL and glycated hemoglobin. Lastly, both DMT2 and DMT2HTN patients demonstrated a significant reduction in HDL. CONCLUSION: DMT2 and DMT2HTN patients have a greater risk of developing cardiovascular related complications. This study suggests that quantifying hs-CRP, IMA and FIB levels can help diagnose the risk of developing complications during the early stages of metabolic and cardiovascular disease. Overall, the specific risk factors may be used for early identification of cardiovascular complications to decrease mortality and morbidity in T2DM patients.
28
The Role of Lipids and Lipoproteins in Atherosclerosis
John W. Gofman, Frank T. Lindgren, Harold A. Elliott et al. · Science · 1950 · 937 citations
Medicine, Cardiology, Aging +10
Type 2 Diabetes: Demystifying the Global Epidemic
Ranjit Unnikrishnan, Rajendra Pradeepa, Shashank Joshi et al. · Diabetes · 2017 · 308 citations
Medicine, Chronic Disease Prevention, Preventive Medicine +17